8 attractions ocean park
ST. SIMONS ISLAND, Ga. (AP) — PGA Tour rookie Patrick Fishburn played bogey-free for an 8-under 64 for his first lead after any round. Joel Dahmen was 10 shots behind and had a bigger cause for celebration Friday in the RSM Classic. Dahmen made a 5-foot par putt on his final hole for a 2-under 68 in tough conditions brought on by the wind and cold, allowing him to make the cut on the number and get two more days to secure his PGA Tour card for next year. He is No. 124 in the FedEx Cup. “I still got more to write this weekend for sure,” said Dahmen, who recently had said his story is not yet over. “But without having the opportunity to play this weekend, my story would be a lot shorter this year.” Fishburn took advantage of being on the easier Plantation course, with trees blocking the brunt of the wind and two additional par 5s. He also was helped by Maverick McNealy, who opened with a 62 on the tougher Seaside course, making two bogeys late in his round and having to settle for a 70. Fishburn, who already has locked up his card for next year, was at 11-under 131 and led McNealy and Lee Hodges (63) going into the weekend. Michael Thorbjornsen had a 69 and was the only player who had to face Seaside on Friday who was among the top five. What mattered on this day, however, was far down the leaderboard. The RSM Classic is the final tournament of the PGA Tour season, and only the top 125 in the FedEx Cup have full status in 2025. That's more critical than ever with the tour only taking the top 100 for full cards after next season. Players like Dahmen will need full status to get as many playing opportunities as they can. That explains why he felt so much pressure on a Friday. He didn't make a bogey after his opening hole and was battling temperatures in the low 50s that felt even colder with the wind ripping off the Atlantic waters of St. Simons Sound. He made a key birdie on the 14th, hitting a 4-iron for his second shot on the 424-yard hole. Dahmen also hit wedge to 2 feet on the 16th that put him on the cut line, and from the 18th fairway, he was safely on the green some 40 feet away. But he lagged woefully short, leaving himself a testy 5-footer with his job on the line. “It was a great putt. I was very nervous,” Dahmen said. “But there's still work to do. It wasn't the game-winner, it was like the half-court shot to get us to halftime. But without that, and the way I played today, I wouldn't have anything this weekend.” His playing partners weren't so fortunate. The tour put three in danger of losing their cards in the same group — Zac Blair (No. 123), Dahmen and Wesley Bryan (No. 125). The cut was at 1-under 141. Blair and Bryan came to the 18th hole needing birdie to be assured of making the cut and both narrowly missed. Now they have to wait to see if anyone passes them, which is typically the case. Thorbjornsen in a tie for fourth and Daniel Berger (66 at Plantation) in a tie for 17th both were projected to move into the top 125. Dahmen, indeed, still has work to do. Fishburn gets a weekend to see if he can end his rookie year with a win. “I've had a lot of experience playing in cold growing up in Utah, playing this time of year, kind of get used to playing when the body’s not moving very well and you’ve got to move your hands,” said Fishburn, who played college golf at BYU. “Just pretty happy with how I played.” Ludvig Aberg, the defending champion and No. 5 player in the world competing for the first time in more than two months because of knee surgery, bounced back with a 64 on Plantation and was back in the mix. Aberg played with Luke Clanton, the Florida State sophomore who looks like he belongs each week. Clanton, the No. 1 player in the world amateur ranking who received a sponsor exemption, had a 65 at Plantation and was two shots off the lead. Clanton already has a runner-up and two other top 10s since June. “Playing with him, it's pretty awesome to watch,” Clanton said. “We were kind of fanboying a little it. I know he's a really good dude but to be playing with him and to see what he's done over the last couple years, it's pretty inspirational.” AP golf: https://apnews.com/hub/golfNoneMinistry of Commerce People's Republic of China (In Chinese)
The chief content officer of troubled Indian tech firm Byju’s and an ally of the company’s founder face financial sanctions in the US for their roles in stripping software, cash and other assets from businesses under court supervision. A federal judge is considering imposing millions of dollars in sanctions on Byju’s manager Vinay Ravindra and company ally Rajendran Vellapalath, who founded Dubai-based tech startup Voizzit Technology. At a court hearing Tuesday, US Bankruptcy Judge John T. Dorsey said he will issue an “order to show cause” that would force the two tech executives to justify their actions, or be declared in contempt of court and be required to pay financial penalties. Lenders owed more than $1.2 billion are fighting to liquidate US education software companies that Byju’s purchased a few years ago for $820 million. Byju’s, founded by controversial entrepreneur Byju Raveendran and his family, is in bankruptcy in India after defaulting on the debt it owes US lenders. Last month, a Nebraska businessman testified that he spent months helping Raveendran try to regain control of Byju’s US software companies, which are being run by a court-supervised trustee. The effort failed and the businessman, William Hailer, ultimately broke with Raveendran and accused the entrepreneur of unethical business tactics. Web Development Intermediate Java Mastery: Method, Collections, and Beyond By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship Building Your Winning Startup Team: Key Strategies for Success By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Finance A2Z Of Finance: Finance Beginner Course By - elearnmarkets, Financial Education by StockEdge View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program Finance Crypto & NFT Mastery: From Basics to Advanced By - CA Raj K Agrawal, Chartered Accountant View Program Entrepreneurship Validating Your Startup Idea: Steps to Ensure Market Fit By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Finance Financial Literacy i.e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Web Development C++ Fundamentals for Absolute Beginners By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Master RESTful APIs with Python and Django REST Framework: Web API Development By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI for Everyone: Understanding and Applying the Basics on Artificial Intelligence By - Ritesh Vajariya, Generative AI Expert View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Java 21 Essentials for Beginners: Build Strong Programming Foundations By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Lenders want the US judge to punish Ravindra, Vellapalath and his firm Voizzit for taking over the cloud-based accounts of the US companies — Epic! Creations and Tangible Play — and draining them of more than $1 million in cash plus valuable internet platforms used by students and other assets. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories Ravindra and a representative for Byju’s did not return an email seeking comment. Vellapalath appeared in court Tuesday by video from Dubai and argued that Voizzit’s actions were legitimate because Voizzit actually owns Epic! and Tangible Play, not Byju’s. Voizzit loaned Byju’s more than $100 million in 2023 and therefore had the right to take ownership of the units, according to Vellapalath. Dorsey rejected that argument during the hearing, saying he did not “find Mr. Vellapalath to be credible.” Raveendran has been trying to regain control of his capsizing education technology empire, which is under court supervision in both India, where the parent is based, and the US, where some of its valuable units are located, according to a court declaration filed by Hailer. In past responses to lender allegations, Raveendran has denied any wrongdoing, saying his actions were a justified response to overly aggressive tactics used by creditors who specialize in squeezing money out of distressed companies. Lenders have been fighting Byju’s in both US state and federal courts for more than a year. Lenders claim Raveendran hid $533 million in loan proceeds that should have been repaid to creditors. Byju’s is also facing an insolvency proceeding in India, where a court-appointed professional has been tasked with raising money to repay lenders.
BRIDGEWATER, NEW JERSEY / ACCESSWIRE / December 6, 2024 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced it has entered into a securities purchase agreement to raise gross proceeds of approximately $2.02 million through a private placement. The agreement includes the issuance of 961,446 shares of common stock (or common stock equivalents) and warrants to purchase up to an additional 480,723 shares of common stock. Each share (or common stock equivalent) is priced at $2.10 and is accompanied by a warrant. The warrants will have an exercise price of $2.031 per share, becoming exercisable six months after issuance and expiring five and one-half years from the date of issuance. The closing of this transaction is expected on or about December 9, 2024, subject to customary closing conditions.
A voter-approved Maine limit on PAC contributions sets the stage for a legal challengeAP Trending SummaryBrief at 1:56 p.m. ESTSEATTLE--(BUSINESS WIRE)--Nov 22, 2024-- Curi Bio, a leader in delivering human functional data to drug discoverers through advanced preclinical tissue models, is proud to announce its selection as one of Deloitte's Technology Fast 500TM companies in 2024, an annual ranking of the 500 fastest-growing technology companies in North America. Curi Bio achieved an overall rank of #123 and secured #18 out of the 70 life sciences companies recognized, highlighting its transformative contribution to enabling the development of next-generation medicines. Curi Bio’s innovative human stem cell platforms deliver functional data that enable biopharmaceutical researchers to make better informed, data-driven decisions during preclinical drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241122635899/en/ Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner (Graphic: Business Wire) "We are honored to be recognized among North America’s most innovative and fastest-growing life sciences companies," said Dr. Nicholas A. Geisse, CEO at Curi Bio. "This recognition reflects the unyielding dedication of our team and the groundbreaking impact of our human-relevant platforms. By providing drug developers tools that more accurately replicate human physiology, our work has accelerated timelines and continues improving the safety and efficacy of new therapies for patients suffering from some of the world’s most devastating diseases." Top global pharmaceutical companies have rapidly adopted Curi Bio’s biological models, driving the company’s strong and steady revenue growth. By delivering predictive, clinically relevant insights, Curi Bio’s technology accelerates the development of safer and more effective drugs, addressing critical challenges in a rapidly evolving industry. The company’s portfolio of functional human disease models spans cardiac, skeletal muscle, and neuromuscular indications, offering researchers powerful tools to tackle some of the most complex diseases beyond the constraints of costly and risky clinical trials. This approach of empowering researchers with turnkey platforms has been a cornerstone of Curi Bio’s growth, earning recognition with this award and demonstrating its pivotal role in advancing medical science. About the 2024 Deloitte Technology Fast 500 Now in its 30th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2020 to 2023. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America. About Curi Bio Curi Bio unlocks novel workflows and delivers functional human data to inform biopharmaceutical R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio melds functional and analytical assessments for drug safety, efficacy, and potency. By offering leading global pharmaceutical end users an integrated preclinical platform along with highly predictive human stem cell tissue models to generate clinically relevant data, Curi Bio is bridging the gap between preclinical R&D and clinical outcomes, accelerating the discovery and development of safer, more effective medicines. For more information, please visit www.curibio.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20241122635899/en/ CONTACT: For media inquiries, please contact: Heejoon Choi Sr. Director of Sales & Marketing, Curi Bio heejoon@curibio.com KEYWORD: UNITED STATES NORTH AMERICA WASHINGTON INDUSTRY KEYWORD: BIOTECHNOLOGY TECHNOLOGY PROFESSIONAL SERVICES HEALTH PHARMACEUTICAL OTHER SCIENCE RESEARCH DATA ANALYTICS ARTIFICIAL INTELLIGENCE SCIENCE CLINICAL TRIALS SOURCE: Curi Bio Copyright Business Wire 2024. PUB: 11/22/2024 01:57 PM/DISC: 11/22/2024 01:57 PM http://www.businesswire.com/news/home/20241122635899/en